Current methods of immune and gene diagnosis in clinical practice


  1. Wolk D., Mitchell S., Patel R. Principles of molecular microbiology testing methods. Infect. Dis. Clin. N. Am. 2001; 15 (4): 1157-1204.
  2. Fredericks D. N., Relman D. A. Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin. Infect. Dis. 1999; 29: 475-488.
  3. Guttmacher А. E., Collins F. S. Welcome to the genomic era. N. Engl. J. Med. 2003; 349 (10): 996-998.
  4. Карпищенко А. И. Медицинские лабораторные технологии. СПб: Интермедика; 1999.
  5. Кэтти Д. Антитела. Методы. М.: Мир; 1991.
  6. Фримель X. Иммунологические методы. М.: Мир; 1989.
  7. Hacek D. М., Suriano Т., Noskin N. et al. Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonality. Am. J. Clin. Pathol. 1999; 111: 647-654.
  8. Anonymous. Recommendations for prevention and control of hepatitis С virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. Morbid. Mortal. Wkly Rep. 1998; 47: 1-39.
  9. Allain J. P. Genomic screening for blood-borne viruses in transfusion settings. Clin. Lab. Haematol. 2000; 22: 1 - 10.
  10. Backman A., Lantz P., Radstrom P. et al. Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples. Mol. Cell Probes 1999; 13: 49-60.
  11. Beggs M. L., Cave M. D., Marlowe C. et al. Chracterization of Mycobacterium tuberculosis complex direct repeate sequence for use in cycling probe reaction. J. Clin. Microbiol. 1996; 34: 2985-2989.
  12. Cook L. Hepatitis С virus diagnosis and therapeutic monitoring: methods and interpretation. Clin. Microbiol. Newsletter 1999; 21: 67-72.
  13. Kahn J. S. Human metapneumovirus: a newly emerging respiratory pathogen. Curr. Opin. Infect. Dis. 2003; 16 (3): 255- 258.
  14. Денисова О. В. Контроль качества иммуноферментного анализа. М.; 2000.
  15. Pitt Т. L., Saunders N. A. Molecular bacteriology: a diagnostic tool for the millenium. J. Cli. Pathol. - 2000; 53: 71-75.
  16. Tang Y. W., Mitchell P. S., Espy M. J. Molecular diagnosis of herpes simplex virus infections in the central nervous system. J. Clin. Microbiol. 1999; 37: 2127-2136.
  17. Tang Y. W., Persing D. H. Molecular detection and identification of microorganisms. In: Murray P. R., Baron E. J., Pfaller M. A. et al. (eds). Manual of clinical microbiology. Washington: FSM Press; 1999. 215-244.
  18. Kelley V. A., Caliendo A. M. Successful testing protocols in virology. Clin. Chem. 2001; 47 (8): 1559-1562.
  19. Ширинский В. С., Старостина Н. М., Сенников Ю. А., Малышева О. А. Проблемы диагностики и классификации вторичных иммунодефицитов. Аллергол. и иммунол. 2000; 1 (1): 62-70.
  20. Salfinger M., Hale Y. M., Driscoll J. R. Diagnostic tools in tuberculosis. Present and future. Respiration 1998; 65: 163-170.
  21. Sanger F., Niclen S., Coulson A. R. DNA sequencing ith chainterminating inhibitors. Proc. Natl. Acad. Sci. USA 1977; 74: 5463-5467.
  22. Shemyakin I. C., Stepanshina V. N., Manzenyuk O. Yu. et al. The use of molecular biological methods for the individual characterization of Mycobacterium tuberculosis strains. Zhurn. Microbiol. Epidemiol. Immunobiol. 2000; 2: 6-11.
  23. Chedore P., Jamieson F. B. Routine use of the Gen-Probe MTD2 amplification test for detection of Mycobacterium tuberculosis in clinical specimens in a large public health mycobacteriology laboratory. Diagn. Microbiol. Infect. Dis. 1999; 35: 185-191.
  24. Shanley T. P., Wong H. R. Molecular genetics in the pediatric intensive care unit. Crit. Care Clin. 2003; 19 (3): 577-594.
  25. Dowsett S. A., Kowolik M. J. Oral Helicobacter pylori: can we stomach it? Crit. Rev. Oral Biol. Med. 2003; 14 (3): 226-233.
  26. O'Duffi J. D., Griffing W. L., Li С. et al. Whipple arthritis. Arth. and Rheum. 1999; 42: 812-817.
  27. Cimino G. D., Metchette К. С., Tessman J. W. Post-PCR sterilization: a method to control carryover contamination for the polymerase chain reaction. Nucleic Acids Res. 1999; 19: 99- 107.
  28. Haass M., Lehmann H. P. New aspects of autoantibodies detection with a new combination of autoantigenic targets. Int. J. Immunorehab. 2000; 2: 19-23.
  29. Walker G. T, Little M. C., Nadeau J. G. et al. Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system. Proc. Natl. Acad. Sci. USA 1992; 89: 392-396.
  30. Chen X., Zehnbauer В., Gnirke A. Fluorescence energy transfer as a homogeneous DNA diagnostic method. Proc. Natl. Acad. Sci. USA 1997; 94: 10756-10761.
  31. Held C. A., Stevens J., Livac K. J. et al. Real time quantitative PCR. Genome Res. 1996; 6: 986-994.
  32. Romano J. W., Williams K. J., Shurtliff R. N. et al. NASBA technology: Isotermal RNA amplification in qualitative and quantitative diagnostics. Immunol. Invest. 1997; 26: 15-28.
  33. Xheng X., Persing D. Genetic amplification techniques for diagnosing infectious diseases. Clin. Chem. 1997; 43 (11): 2021- 2038.
  34. Debruyne P. R., Waldman S. A., Schulz S. Pathological staging and therapy of oesophageal and gastric cancer. Expert Opin. Pharmacother. 2003; 4 (7): 1083-1096.
  35. Goble S., Bear H. D. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions. Surg. Clin. N. Am. 2003; 83 (4): 943-971.
  36. Singletary S. E., Allred C., Ashley P. et al. Staging system for breast cancer: revisions for the 6-th edition of the AJCC Cancer Staging Manual. Surg. Clin. N. Am. 2003; 83 (4): 803819.
  37. Kimura Y. Recent progress in the treatment of acute leukemia. Gan To Kagaku Ryoho 2003; 30 (7): 895-901.
  38. Методические рекомендации тест-системы для количественного определения ПСА в сыворотке и плазме крови человека. М.: Хема-Медика; 2002.
  39. Wright С. Е. Ethical, legal, and social implications of genomic medicine. N. Engl. J. Med. 2003; 349: 562-569.
  40. Cockerill F. R. III. Genetic methods for assessing antimicrobial resistance. Antimicrob. Agents Chemother. 1999; 43: 1999- 2012.
  41. Nolte F. S. Impact of viral load testing on patient care. Arch. Pathol. Lab. Med. 1999; 123: 1011-1014.
  42. Elbeik Т., Charlebois E., Nassos P. et al. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J. Clin. Microbiol. 2000; 38: 1113-1120.
  43. Wilson J. W., Bean P. A physicians's primer to antiretroviral drag resistance testing. AIDS Reader 2000; 10: 469-473.
  44. Fairweather D., Ziya Kaya, Shellam G. R. et al. From infection to autoimmunity. J. Autoimmun. 2001; 16: 175-186.
  45. Nabel E. G. Cardiovascular disease. N. Engl. J. Med. 2003; 349: 60-72.
  46. Relman D. A. Detection and identification of previously unrecognized microbial pathogens. Emerg. Infect. Dis. 1998; 4: 382-389.
  47. Alizadeh M., Babron M. C., Birebent B. et al. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann. Neurol. 2003; 54 (1): 119-122.
  48. Chudy M., Hewlett J., Saldanha J. et al. Technical considerations for the performance of Nucleic acid Amplification Technology (NAT). The NAT Task Force Group. Biologicals 2003; 31 (3): 153-159.
  49. Bergeron M. G., Quellette M. Preventing antibiotic resistance using rapid DNA-based diagnostic tests. Infect. Control. Hosp. Epidemiol. 1998; 19: 560-564.
  50. Saldanha J. Standardization: A progress report. Biologicals 1999; 27: 285-289.
  51. Lyamichev V., Mast A. L., Hall J. G. et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat. Biotechnol. 1999; 17: 292-296.
  52. Louie M., Louie L., Simor A. E. The role of DNA amplification technology in the diagnosis of infectious diseases. Can. Med. Assoc. 2000; 163 (3): 301-309.



Abstract - 98


Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Copyright (c) 2004 Suchkov S.V., Moskalets О.V., Cherepakhina N.E., Burdakova Y.A., Suntsova I.G., Shumsky V.I., Shaikhaev G.O., Elbeik Т., Beringer S., Petrauskene O.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies